Literature DB >> 18938102

Pivotal role for TGF-beta in infectious heart disease: The case of Trypanosoma cruzi infection and consequent Chagasic myocardiopathy.

Tania C Araújo-Jorge1, Mariana C Waghabi, Maria de Nazaré C Soeiro, Michelle Keramidas, Sabine Bailly, Jean-Jacques Feige.   

Abstract

This paper summarizes recent data from the literature suggesting that transforming growth factor-beta (TGF-beta) participates at least in four different processes influencing development of myocardiopathy in Chagas disease, a major parasitic illness caused by Trypanosoma cruzi infection: (a) invasion of cardiac fibroblasts and myocytes; (b) intracellular parasite cycle; (c) regulation of inflammation and immune response; (d) fibrosis and heart remodeling during acute and chronic disease. All these effects point to an important role of TGF-beta in Chagas disease myocardiopathy and suggest that monitoring the circulating levels of this cytokine could be of help in clinical prognosis and management of patients. Moreover, TGF-beta-interfering therapies appear as interesting adjuvant interventions during acute and chronic phases of T. cruzi infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18938102     DOI: 10.1016/j.cytogfr.2008.08.002

Source DB:  PubMed          Journal:  Cytokine Growth Factor Rev        ISSN: 1359-6101            Impact factor:   7.638


  26 in total

Review 1.  Gap junctions and chagas disease.

Authors:  Daniel Adesse; Regina Coeli Goldenberg; Fabio S Fortes; Dumitru A Iacobas; Sanda Iacobas; Antonio Carlos Campos de Carvalho; Maria de Narareth Meirelles; Huan Huang; Milena B Soares; Herbert B Tanowitz; Luciana Ribeiro Garzoni; David C Spray
Journal:  Adv Parasitol       Date:  2011       Impact factor: 3.870

Review 2.  Pathogenesis of chagas' disease: parasite persistence and autoimmunity.

Authors:  Antonio R L Teixeira; Mariana M Hecht; Maria C Guimaro; Alessandro O Sousa; Nadjar Nitz
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

3.  Characterization of Trypanosoma cruzi infectivity, proliferation, and cytokine patterns in gut and pancreatic epithelial cells maintained in vitro.

Authors:  Laura A Martello; Raj Wadgaonkar; Raavi Gupta; Fabiana S Machado; Michael G Walsh; Eduardo Mascareno; Herbert B Tanowitz; M A Haseeb
Journal:  Parasitol Res       Date:  2013-09-10       Impact factor: 2.289

4.  Circulating serum markers and QRS scar score in Chagas cardiomyopathy.

Authors:  Eva H Clark; Morgan A Marks; Robert H Gilman; Antonio B Fernandez; Thomas C Crawford; Aaron M Samuels; Alicia I Hidron; Gerson Galdos-Cardenas; Gilberto Silvio Menacho-Mendez; Ricardo W Bozo-Gutierrez; Diana L Martin; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2014-11-10       Impact factor: 2.345

Review 5.  Transforming growth factor-β in myocardial disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Nat Rev Cardiol       Date:  2022-01-04       Impact factor: 32.419

6.  Inhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.

Authors:  Aparecida D Malvezi; Carolina Panis; Rosiane V da Silva; Rafael Carvalho de Freitas; Maria I Lovo-Martins; Vera L H Tatakihara; Nágela G Zanluqui; Edecio Cunha Neto; Samuel Goldenberg; Juliano Bordignon; Sueli F Yamada-Ogatta; Marli C Martins-Pinge; Rubens Cecchini; Phileno Pinge-Filho
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

7.  Pharmacological inhibition of transforming growth factor beta signaling decreases infection and prevents heart damage in acute Chagas' disease.

Authors:  Mariana C Waghabi; Elen M de Souza; Gabriel M de Oliveira; Michelle Keramidas; Jean-Jacques Feige; Tania C Araújo-Jorge; Sabine Bailly
Journal:  Antimicrob Agents Chemother       Date:  2009-09-08       Impact factor: 5.191

Review 8.  Regulatory T cells phenotype in different clinical forms of Chagas' disease.

Authors:  Fernanda Fortes de Araújo; Danielle Marquete Vitelli-Avelar; Andréa Teixeira-Carvalho; Paulo Renato Antas; Juliana Assis Silva Gomes; Renato Sathler-Avelar; Manoel Otávio Costa Rocha; Silvana Maria Elói-Santos; Rosa Teixeira Pinho; Rodrigo Correa-Oliveira; Olindo Assis Martins-Filho
Journal:  PLoS Negl Trop Dis       Date:  2011-05-31

9.  Oral administration of GW788388, an inhibitor of transforming growth factor beta signaling, prevents heart fibrosis in Chagas disease.

Authors:  Fabiane L de Oliveira; Tania C Araújo-Jorge; Elen M de Souza; Gabriel M de Oliveira; Wim M Degrave; Jean-Jacques Feige; Sabine Bailly; Mariana C Waghabi
Journal:  PLoS Negl Trop Dis       Date:  2012-06-12

Review 10.  The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection.

Authors:  Carlos Gustavo Vieira de Morais; Ana Karina Castro Lima; Rodrigo Terra; Rosiane Freire dos Santos; Silvia Amaral Gonçalves Da-Silva; Patrícia Maria Lourenço Dutra
Journal:  Biomed Res Int       Date:  2015-05-18       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.